TIVO-3: Tivozanib as Third- or Later-Line Therapy in Clear-Cell RCC
                        1 year ago
                        38
                    - Homepage
 - category-label-
 - TIVO-3: Tivozanib as Third- or Later-Line Therapy in Clear-Cell RCC
 
Related
Trending
Popular
Reduce your risk of cancer: get involved and have fun
                                1 year ago 
                                227            
        Copyright © 2019 - 2025 | Whatiscancer.net | All Rights Reserved.






                        English (US)  ·